MCRB Stock Analysis: Buy, Sell, or Hold?

MCRB - Seres Therapeutics, Inc.

PHARMACEUTICAL PREPARATIONS
$5.03
0.20 (4.14%) ▲
5d: +3.71%
30d: -35.01%
90d: -33.9%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026 TODAY

Get Alerted When MCRB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: MCRB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: MCRB is currently trading at $5.03, which is considered slightly low relative to its 30-day fair value range of $4.79 to $7.21.

Technical Outlook: Technically, MCRB is in a strong downtrend. Immediate support is located at $4.59, while resistance sits at $5.44. The stock is showing strong short-term momentum, up 4.1% recently.

Market Sentiment: MCRB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (4th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $17.00 (+238.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $4.79 - $7.21
Company Quality Score 44/100 (HOLD)
Options IV Signal 4th percentile (LOW)
Volume Confirmation HIGH
Confidence Score 70.8%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 4th percentile)
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.1%)
  • BULLISH: Trading 238.0% below Wall St target ($17.00)

Trading Range Analysis

30-Day Trading Range $4.79 - $7.21
Current vs Trading Range SLIGHTLY LOW
Expected Move (7 Days) ±$0.82 (16.4%)

Support & Resistance Levels

Support Level $4.59
Resistance Level $5.44
Current Trend Strong Downtrend
Technical data as of Aug 3, 2026

Fundamental Context

Forward P/E (Next Year Est.) -0.77
Wall Street Target $17.00 (+238.0%)
Revenue Growth (YoY) -93.4%
Earnings Growth (YoY) -91.9%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 04, 2026 6:08 AM ET
Data refreshes hourly during market hours. Next update: 7:08 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for MCRB.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$22 49 HOLD
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1080 57 HOLD
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$52 54 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$127 59 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD

Advanced MCRB Option Strategies

Professional options setups generated by AI based on today's MCRB price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for MCRB

MCRB Technical Chart MCRB Price Prediction MCRB Earnings Date MCRB Investment Advisor MCRB Fair Price Analyzer MCRB Options Advisor MCRB Options Chain MCRB Options Analysis MCRB Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals